Identification of Bacterial Metabolites Modulating Breast Cancer Cell Proliferation and Epithelial-Mesenchymal Transition
Open Access
Abstract
Breast cancer patients are characterized by the oncobiotic transformation of multiple microbiome communities, including the gut microbiome. Oncobiotic transformation of the gut microbiome impairs the production of antineoplastic bacterial metabolites. The goal of this study was to identify bacterial metabolites with antineoplastic properties. We constructed a 30-member bacterial metabolite library and screened the library compounds for effects on cell proliferation and epithelial-mesenchymal transition. The metabolites were applied to 4T1 murine breast cancer cells in concentrations corresponding to the reference serum concentrations. However, yric acid, glycolic acid, d-mannitol, 2,3-butanediol, and trans-ferulic acid exerted cytostatic effects, and 3-hydroxyphenylacetic acid, 4-hydroxybenzoic acid, and vanillic acid exerted hyperproliferative effects. Furthermore, 3-hydroxyphenylacetic acid, 4-hydroxybenzoic acid, 2,3-butanediol, and hydrocinnamic acid inhibited epithelial-to-mesenchymal (EMT) transition. We identified redox sets among the metabolites (d-mannitol—d-mannose, 1-butanol—butyric acid, ethylene glycol—glycolic acid—oxalic acid), wherein only one partner within the set (d-mannitol, butyric acid, glycolic acid) possessed bioactivity in our system, suggesting that changes to the local redox potential may affect the bacterial secretome. Of the nine bioactive metabolites, 2,3-butanediol was the only compound with both cytostatic and anti-EMT properties.Keywords
Funding Information
- Nemzeti Kutatási és Technológiai Hivatal (K123975, K142141, FK128387, POST-COVID2021-33, TKP2021-EGA-19, TKP2021-EGA-20, TKP2021-EGA)
- Magyar Tudományos Akadémia (K123975, K142141, FK128387, POST-COVID2021-33, TKP2021-EGA-19, TKP2021-EGA-20, TKP2021-EGA)
- University of Debrecen (K123975, K142141, FK128387, POST-COVID2021-33, TKP2021-EGA-19, TKP2021-EGA-20, TKP2021-EGA)
- Nemzeti Kutatási és Technológiai Hivatal (K123975, K142141, FK128387, POST-COVID2021-33, TKP2021-EGA-19, TKP2021-EGA-20, TKP2021-EGA)
- Bolyai Fellowship of the Hungarian Academy of Sciences (K123975, K142141, FK128387, POST-COVID2021-33, TKP2021-EGA-19, TKP2021-EGA-20, TKP2021-EGA)
This publication has 113 references indexed in Scilit:
- Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with EpilepsyScience, 2012
- Production of 2,3-butanediol in Saccharomyces cerevisiae by in silico aided metabolic engineeringMicrobial Cell Factories, 2012
- The Human Serum MetabolomePLOS ONE, 2011
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- Oestrogenic activity ofp-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell linesJournal of Applied Toxicology, 2005
- Glycolate determination detects type I primary hyperoxaluria in dialysis patientsKidney International, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Radioenzymatic assay for plasma dihydroxyphenylglycol (DHPG), dihydroxymandelic acid (DOMA) and dihydroxyphenylacetic acid (DOPAC)Life Sciences, 1983
- GUT BACTERIA AND ÆTIOLOGY OF CANCER OF THE BREASTThe Lancet, 1971